Lookzadeh Somayeh, Seyyedi Seyyed Reza, Jamaati Hamidreza, Miraboutalebi Fatemehalsadat, Rekabi Mahsa
Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Lung transplantation Research center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2024 Mar;23(3):294-299.
Chronic obstructive pulmonary disease (COPD) is an inflammatory systemic disorder that affects the respiratory tract airways and breathing. Left ventricular diastolic dysfunction (LVDD), which is the inability of the ventricle to fill to a normal end-diastolic volume, may be observed in patients with severe COPD. This study aimed to evaluate LVDD in patients with COPD.
This cross-sectional study included 58 patients under 65 years of age with COPD as the case group. Moreover, 58 patients with normal spirometry and without pulmonary or cardiac disease were included as the control group. They referred to the cardiologist for echocardiography. Patients were tested for C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptides (NT -pro BNP). Data were analyzed with SPSS for descriptive reports of the relationship between variables.
The results showed that LVDD was significantly higher in COPD patients (60%) than in the control group (12.2%). Also, there was no significant relationship between LVDD and BMI in COPD patients. Evaluation of CRP and PRO-BNP showed that the distribution of patients in different diastolic function classes is similar. It was observed that with increasing COPD severity, LVDD severity increased (p-value =0.101). There is a direct relationship between total lung capacity (TLC) and LVDD (P-value <0.0001). In COPD patients, there was a significant relationship between diastolic function and SPAP (P-value <0.0019).
In general, it should be noted that the prevalence of LVDD in patients with COPD is significantly higher than in other people.
慢性阻塞性肺疾病(COPD)是一种影响呼吸道气道和呼吸的炎症性全身性疾病。左心室舒张功能障碍(LVDD),即心室无法充盈至正常舒张末期容积,在重度COPD患者中可能会出现。本研究旨在评估COPD患者的LVDD。
这项横断面研究纳入了58名65岁以下的COPD患者作为病例组。此外,纳入了58名肺活量测定正常且无肺部或心脏疾病的患者作为对照组。他们被转介给心脏病专家进行超声心动图检查。对患者进行C反应蛋白(CRP)和N末端B型利钠肽原(NT-pro BNP)检测。使用SPSS对数据进行分析,以得出变量之间关系的描述性报告。
结果显示,COPD患者中LVDD的发生率(60%)显著高于对照组(12.2%)。此外,COPD患者中LVDD与体重指数(BMI)之间无显著关系。对CRP和PRO-BNP的评估表明,不同舒张功能类别的患者分布相似。观察到随着COPD严重程度的增加,LVDD严重程度也增加(p值 = 0.101)。肺总量(TLC)与LVDD之间存在直接关系(P值 < 0.0001)。在COPD患者中,舒张功能与肺动脉收缩压(SPAP)之间存在显著关系(P值 < 0.0019)。
总体而言,应注意到COPD患者中LVDD的患病率显著高于其他人。